| 2001 |
HRC binds directly to triadin (an integral membrane protein of the sarcoplasmic reticulum) in the SR lumen, as demonstrated by co-immunoprecipitation. The histidine-rich acidic repeats of HRC were identified as responsible for this binding via fusion protein binding assay. The HRC-binding domain of triadin was localized to the lumenal region containing the KEKE motif. Importantly, the interaction is Ca2+-sensitive. |
Co-immunoprecipitation and fusion protein binding assay |
The Journal of biological chemistry |
High |
11504710
|
| 1999 |
HRC exists as a multimeric complex (likely larger than a pentamer) under physiological conditions in the SR lumen; at higher Ca2+ concentrations the complex dissociates into dimers or trimers. HRC resides in the lumen of the SR (not the membrane), confirmed by tryptic digestion and biotinylation of SR vesicles. |
Native gel electrophoresis, tryptic digestion of SR vesicles, biotinylation assay |
Biochemical and biophysical research communications |
Medium |
10512736
|
| 2003 |
Overexpression of HRC in rat neonatal cardiomyocytes increases SR Ca2+ storage capacity: caffeine-induced and depolarization-induced Ca2+ release were significantly increased, and SR Ca2+ content (measured by cyclopiazonic acid depletion) remained elevated. Ryanodine receptor density and binding kinetics were not significantly altered, implicating HRC primarily in SR Ca2+ buffering. |
Overexpression in neonatal cardiomyocytes, Ca2+ imaging, ryanodine binding assay |
Biochemical and biophysical research communications |
Medium |
12480542
|
| 2004 |
HRC gene expression in cardiac, skeletal, and arterial smooth muscle is directly controlled by MEF2 transcription factor. A conserved MEF2 binding site in the HRC enhancer was shown to be required for expression in all three muscle lineages in transgenic mice. The HRC enhancer lacks CArG motifs and is not activated by SRF, making HRC the first MEF2-dependent, CArG-independent SR gene transcriptional target in smooth muscle. |
Transgenic mouse enhancer-lacZ reporter assay, electrophoretic mobility shift assay (EMSA), mutagenesis of MEF2 site |
Molecular and cellular biology |
High |
15082771
|
| 2013 |
Ablation of HRC (knockout mice) results in enhanced SR Ca2+ uptake, enhanced contractility, and elevated SR Ca2+ load, but also increased spontaneous Ca2+ release (sparks, waves) and delayed afterdepolarizations under stress conditions. Under pressure-overload (TAC), HRC-KO mice show severely deteriorated cardiac function, hypertrophy, fibrosis, and decreased survival, associated with depressed SERCA2a expression, indicating HRC is required for maintaining integrity of cardiac Ca2+ cycling under pathophysiological stress. |
HRC knockout mouse model, cardiomyocyte Ca2+ imaging, contractility measurements, SR Ca2+ uptake assay, TAC model |
Basic research in cardiology |
High |
23553082
|
| 2014 |
The human HRC Ser96Ala (S96A) mutation impairs the ability of HRC to buffer intra-store free Ca2+ and inhibit store overload-induced Ca2+ release (SOICR) via RyR2. Wild-type HRC significantly inhibits SOICR by buffering store Ca2+ and inhibiting Ca2+ uptake; the S96A mutant has a markedly suppressed inhibitory effect. A proximity ligation assay showed the S96A mutation also disrupts the Ca2+ microdomain around RyR2 by altering the Ca2+-dependent association of RyR2 and HRC. These effects occur independently of triadin. |
HEK293 cell expression of RyR2, cytosolic and intra-store Ca2+ measurements, proximity ligation assay, mutagenesis |
Journal of molecular and cellular cardiology |
High |
24805197
|
| 2015 |
Ablation of HRC in CASQ2 knockout mice (double knockout) alleviates catecholamine-dependent arrhythmia and reduces spontaneous Ca2+ waves and sparks compared to CASQ2-KO alone, and slows SR Ca2+ release restitution. This epistasis demonstrates that CASQ2 and HRC modulate cardiac RyR2-mediated Ca2+ release in opposing manners: CASQ2 stabilizes RyR2 (rendering it refractory), while HRC enhances RyR2 activity and facilitates recovery from refractoriness. |
Double knockout mouse model, Ca2+ imaging, arrhythmia measurement under isoproterenol challenge |
Cardiovascular research |
High |
26410369
|
| 2015 |
HRC promotes hepatocellular carcinoma cell invasion and migration through Ca2+/CaM signaling-mediated FAK phosphorylation and focal adhesion turnover. Mechanistically, HRC increases cytosolic Ca2+ by inhibiting SERCA2 expression. Knockdown of HRC suppresses invasion/migration, while ectopic expression enhances metastasis in vivo. SATB1 was identified as an upstream transcriptional activator of HRC via AP-1 (JNK-dependent). |
siRNA knockdown, ectopic overexpression, in vitro invasion/migration assays, in vivo metastasis model, Ca2+ measurement, FAK phosphorylation western blot, SATB1 reporter assay |
Oncotarget |
Medium |
25762622
|
| 2017 |
Knockdown of HRC in hepatic stellate cells (HSCs) inhibits HSC activation (reduced α-SMA, CTGF, collagen expression, proliferation, migration) through suppression of ER stress and autophagy. TGF-β-induced HSC activation is associated with increased HRC expression. The anti-fibrotic effect of HRC knockdown is mediated via the ER stress pathway. |
siRNA knockdown in HSC lines, TGF-β stimulation, western blot for activation/ER stress markers, proliferation and migration assays |
Biology open |
Medium |
27881436
|
| 2017 |
The homologous HRC Ser81Ala knock-in mouse (equivalent to human Ser96Ala) exhibits stress-induced ventricular arrhythmias, increased SR Ca2+ leak without increased Ca2+ spark frequency, slower Ca2+ wave propagation, prolonged action potential duration, and increased CaMKII phosphorylation of RyR2. CaMKII inhibitor KN-93 reduced arrhythmia occurrence, placing CaMKII downstream of the HRC Ser96Ala variant in the arrhythmia mechanism. |
Knock-in mouse model, Ca2+ imaging, electrophysiology, CaMKII inhibitor treatment, western blot for phospho-RyR2 |
Cardiovascular research |
High |
28859293
|
| 2012 |
siRNA-mediated HRC knockdown in neonatal cardiomyocytes enhances Ca2+ cycling and increases RyR2 and SERCA2 activities without changing SR Ca2+ load. However, AAV-mediated HRC knockdown in pressure-overloaded (TAC) failing hearts exacerbates cardiac dysfunction and fibrosis, associated with increased phospho-RyR2, phospho-CaMKII, phospho-p38 MAPK, phospho-PLB, and caspase-3 cleavage, indicating that HRC loss in a stressed heart activates CaMKII/p38 MAPK death pathway. |
siRNA knockdown in NRVCs, AAV9-mediated knockdown in TAC mouse model, Ca2+ imaging, western blot, TUNEL assay |
PloS one |
High |
22952658
|
| 2020 |
Vitamin D reduces HRC expression in liver fibrosis (in vivo CCl4 model and in vitro TGF-β1-stimulated LX-2 cells). HRC overexpression increases TGF-β1/Smad3 signaling and S-phase cell cycle entry. HRC was identified as a direct transcriptional target of the vitamin D receptor (VDR) by chromatin immunoprecipitation (ChIP). Vitamin D reverses HRC-induced TGF-β/Smad signaling. |
ChIP assay for VDR at HRC locus, western blot for TGF-β1/Smad3, cell cycle analysis, in vivo CCl4 fibrosis model |
Chemico-biological interactions |
Medium |
33309619
|
| 2021 |
HRC promotes anoikis resistance in hepatocellular carcinoma cells via suppression of ER stress. Modulating HRC level changes ER stress to affect anoikis resistance through the PERK-eIF2α-ATF4-CHOP signaling axis. HRC overexpression also promoted in vivo metastasis. |
HRC knockdown/overexpression, suspension culture anoikis assay, western blot for PERK/eIF2α/ATF4/CHOP, in vivo metastasis model |
International journal of medical sciences |
Medium |
34400882
|
| 2022 |
HRC overexpression in hepatocytes induces pyroptosis and HMGB1 release, leading to hepatic stellate cell activation via the NLRP3/caspase-1 pathway. NLRP3 inhibitor MCC950 and caspase-1 inhibitor VX-765 alleviated HRC-mediated pyroptosis and HSC activation. |
HRC overexpression in hepatocytes, pyroptosis assays, HMGB1 measurement, pharmacological inhibition of NLRP3 (MCC950) and caspase-1 (VX-765), HSC activation markers |
Journal of molecular medicine (Berlin, Germany) |
Medium |
36371595
|